Althea Group Holdings Ltd (AU:AGH) — Market Cap & Net Worth
Market Cap & Net Worth: Althea Group Holdings Ltd (AGH)
Althea Group Holdings Ltd (AU:AGH) has a market capitalization of $12.05 Million (AU$17.03 Million) as of September 22, 2026. Listed on the AU stock exchange, this Australia-based company holds position #26669 globally and #1232 in its home market, demonstrating a -10.53% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Althea Group Holdings Ltd's stock price AU$0.02 by its total outstanding shares 1001813856 (1.00 Billion). Also see AGH asset base for a full breakdown of the balance sheet.
Althea Group Holdings Ltd Market Cap History: 2018 to 2026
Althea Group Holdings Ltd's market capitalization history from 2018 to 2026. Data shows change from $173.67 Million to $12.05 Million (-37.71% CAGR). Also see cash flow conversion of Althea Group Holdings Ltd for how efficiently the company converts equity into cash flow.
Althea Group Holdings Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Althea Group Holdings Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check AGH share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.87x
Althea Group Holdings Ltd's market cap is 0.87 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $173.67 Million | $10.72K | -$1.87 Million | 16200.33x | N/A |
| 2019 | $265.82 Million | $767.00K | -$8.68 Million | 346.57x | N/A |
| 2020 | $308.35 Million | $4.97 Million | -$14.77 Million | 62.03x | N/A |
| 2021 | $159.49 Million | $11.07 Million | -$15.05 Million | 14.40x | N/A |
| 2022 | $43.24 Million | $20.08 Million | -$12.12 Million | 2.15x | N/A |
| 2023 | $27.65 Million | $24.82 Million | -$13.72 Million | 1.11x | N/A |
| 2024 | $24.10 Million | $29.40 Million | -$32.06 Million | 0.82x | N/A |
| 2025 | $13.47 Million | $15.49 Million | -$8.35 Million | 0.87x | N/A |
Competitor Companies of AGH by Market Capitalization
Companies near Althea Group Holdings Ltd in the global market cap rankings as of September 22, 2026. Review Althea Group Holdings Ltd (AGH) tangible net worth to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Althea Group Holdings Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #521 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #596 globally with a market cap of $45.64 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #638 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #648 globally with a market cap of $42.98 Billion USD ( CN¥293.69 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #521 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #596 | GALDERMA GROUP AG | NYSE:GALDY | $45.64 Billion | $39.14 |
| #638 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.30 |
| #648 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $42.98 Billion | CN¥46.04 |
Althea Group Holdings Ltd Historical Marketcap From 2018 to 2026
Between 2018 and today, Althea Group Holdings Ltd's market cap moved from $173.67 Million to $ 12.05 Million, with a yearly change of -37.71%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$12.05 Million | -10.53% |
| 2025 | AU$13.47 Million | -44.12% |
| 2024 | AU$24.10 Million | -12.82% |
| 2023 | AU$27.65 Million | -36.07% |
| 2022 | AU$43.24 Million | -72.89% |
| 2021 | AU$159.49 Million | -48.28% |
| 2020 | AU$308.35 Million | +16.00% |
| 2019 | AU$265.82 Million | +53.06% |
| 2018 | AU$173.67 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 22nd, 2026 the market cap of Althea Group Holdings Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.05 Million USD |
| MoneyControl | $12.05 Million USD |
| MarketWatch | $12.05 Million USD |
| marketcap.company | $12.05 Million USD |
| Reuters | $12.05 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Althea Group Holdings Ltd
Peak Processing Limited, together with its subsidiaries, manufactures, distributes, and sells recreational cannabis products in Canada and the United States. The company offers cannabis products, including beverages, hydrocarbon extracts, oils, vapes, oils, topicals, powders, infused flowers, and edibles. It also provides market insights and analysis, product development, manufacturing, commercia… Read more